N-(2-Mercaptoethyl)-1,3-thiazolidine
Common Name: |
N-(2-Mercaptoethyl)-1,3-thiazolidine |
IUPAC Name: |
2-(1,3-thiazolidin-3-yl)ethanethiol |
Molecular Formula: |
C9H12O2 |
SMILES: |
C1CSCN1CCS |
Inchi: |
1S/C5H11NS2/c7-3-1-6-2-4-8-5-6/h7H,1-5H2 |
Inchi Key: |
QZSFSYKRUWBUHJ-UHFFFAOYSA-N |
Cas No: |
317803-03-5 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
152.19 |
Mass (g/mol) |
149.033 |
Molar Refractivity |
44.13 |
Net Charge |
|
HBD |
1 |
HBA |
2 |
Rt Bonds |
3 |
Rings |
1 |
TPSA |
29.46 |
Hetero Atoms |
3 |
Heavy Atoms |
11 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
246.00 to 248.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.027 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.33 |
LogP |
0.923 |
iLOGP |
1.97 |
XLOGP3 |
1.08 |
WLOGP |
1.78 |
MLOGP |
1.53 |
ESOL Log S |
-1.67 |
ESOL Solubility (mg/ml) |
3.26 |
ESOL Solubility (mol/l) |
0.021 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.29 |
Ali Solubility (mg/ml) |
7.79 |
Ali Solubility (mol/l) |
0.05 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-2.74 |
Silicos-IT Solubility (mg/ml) |
0.28 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.46 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.351 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.952 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
1 |